A Delphi consensus statement for the management of post-COVID interstitial lung disease.

IF 2.9 3区医学 Q2 RESPIRATORY SYSTEM

Expert Review of Respiratory Medicine Pub Date : 2022-09-01 Epub Date: 2022-09-30 DOI:10.1080/17476348.2022.2128770

Vijay Hadda, Tejas M Suri, Hariharan Iyer, Avinash Jain, Saurabh Mittal, Karan Madan, Anant Mohan, Ashu Seith Bhalla, Girish Sindhwani, Naveen Dutt, Kavitha Venkatnarayan, Alok Nath, Sahajal Dhooria, Rohit Kumar, Vikas Marwah, Saurabh Karmakar, Dhruva Chaudhry, Irfan Ismail Ayub, Dharm Prakash Dwivedi, Pawan Tiwari, Parvaiz Koul, Ajoy Kumar Behera, Puneet Saxena, Amitabha Sengupta, Prasanta R Mohapatra, Abhishek Goyal, Devasahayam J Christopher, Randeep Guleria

{"title":"A Delphi consensus statement for the management of post-COVID interstitial lung disease.","authors":"Vijay Hadda, Tejas M Suri, Hariharan Iyer, Avinash Jain, Saurabh Mittal, Karan Madan, Anant Mohan, Ashu Seith Bhalla, Girish Sindhwani, Naveen Dutt, Kavitha Venkatnarayan, Alok Nath, Sahajal Dhooria, Rohit Kumar, Vikas Marwah, Saurabh Karmakar, Dhruva Chaudhry, Irfan Ismail Ayub, Dharm Prakash Dwivedi, Pawan Tiwari, Parvaiz Koul, Ajoy Kumar Behera, Puneet Saxena, Amitabha Sengupta, Prasanta R Mohapatra, Abhishek Goyal, Devasahayam J Christopher, Randeep Guleria","doi":"10.1080/17476348.2022.2128770","DOIUrl":null,"url":null,"abstract":"Introduction: As millions of people worldwide recover from COVID-19, a substantial proportion continue to have persistent symptoms, pulmonary function abnormalities, and radiological findings suggestive of post-COVID interstitial lung disease (ILD). To date, there is limited scientific evidence on the management of post-COVID ILD, necessitating a consensus-based approach.Areas covered: A panel of experts in pulmonology and thoracic radiology was constituted. Key questions regarding the management of post-COVID ILD were identified. A search was performed on PubMed and EMBASE and updated till 1 March 2022. The relevant literature regarding the epidemiology, pathophysiology, diagnosis and treatment of post-COVID ILD was summarized. Subsequently, suggestions regarding the management of these patients were framed, and a consensus was obtained using the Delphi approach. Those suggestions which were approved by over 80% of the panelists were accepted. The final document was approved by all panel members.Expert opinion: Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17476348.2022.2128770","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: As millions of people worldwide recover from COVID-19, a substantial proportion continue to have persistent symptoms, pulmonary function abnormalities, and radiological findings suggestive of post-COVID interstitial lung disease (ILD). To date, there is limited scientific evidence on the management of post-COVID ILD, necessitating a consensus-based approach.

Areas covered: A panel of experts in pulmonology and thoracic radiology was constituted. Key questions regarding the management of post-COVID ILD were identified. A search was performed on PubMed and EMBASE and updated till 1 March 2022. The relevant literature regarding the epidemiology, pathophysiology, diagnosis and treatment of post-COVID ILD was summarized. Subsequently, suggestions regarding the management of these patients were framed, and a consensus was obtained using the Delphi approach. Those suggestions which were approved by over 80% of the panelists were accepted. The final document was approved by all panel members.

Expert opinion: Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.

查看原文本刊更多论文

关于covid - 19后间质性肺疾病管理的德尔菲共识声明

导言:随着全球数百万人从COVID-19中康复，相当大比例的人仍有持续症状、肺功能异常和影像学表现提示后COVID-19间质性肺病(ILD)。迄今为止，关于covid - 19后ILD管理的科学证据有限，因此需要采用基于共识的方法。涉及领域:组成了一个肺病学和胸部放射学专家小组。确定了有关covid后ILD管理的关键问题。在PubMed和EMBASE上进行了检索，并更新至2022年3月1日。本文综述了covid - 19后ILD的流行病学、病理生理学、诊断和治疗等相关文献。随后，对这些患者的管理提出建议，并使用德尔菲法获得共识。经超过80%的小组成员认可的建议被采纳。最后的文件得到了全体小组成员的批准。专家意见:应该建立专门的设施来照顾covid - 19后ILD患者。症状筛查、肺功能检查和胸部影像学检查对诊断有一定作用。讨论了治疗covid后ILD的药物和非药物选择。对covid - 19后ILD的病理生理学和管理的进一步研究将提高我们对这种情况的理解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Respiratory Medicine RESPIRATORY SYSTEM-

CiteScore

6.80

自引率

2.60%

发文量

期刊介绍： Coverage will include the following key areas: - Prospects for new and emerging therapeutics - Epidemiology of disease - Preventive strategies - All aspects of COPD, from patient self-management to systemic effects of the disease and comorbidities - Improved diagnostic methods, including imaging techniques, biomarkers and physiological tests. - Advances in the treatment of respiratory infections and drug resistance issues - Occupational and environmental factors - Progress in smoking intervention and cessation methods - Disease and treatment issues for defined populations, such as children and the elderly - Respiratory intensive and critical care - Updates on the status and advances of specific disease areas, including asthma, HIV/AIDS-related disease, cystic fibrosis, COPD and sleep-disordered breathing morbidity

文献相关原料

公司名称	产品信息	采购帮参考价格